from the helm: immutep's (asx:imm, nasdaq:immp) executive director & ceo marc voigt
Published 2 years ago • 144 plays • Length 7:13
Download video MP4
Download video MP3
Similar videos
-
7:13
from the helm: immutep's (asx:imm) executive director & ceo marc voigt
-
12:28
immutep (asx:imm, nasdaq:immp) ceo marc voigt provides an update on clinical trials
-
4:32
immutep limited (asx:imm; nasdaq:immp) ceo and executive director marc voigt provides company update
-
15:49
immutep (asx:imm) - webinar presentation
-
5:10
immutep (asx:imm, nasdaq:immp) reports first subject dosed in autoimmune disease study
-
10:50
us military helmets (m1 to pasgt to lwh/ach) - surplus collection guide
-
13:08
forcite helmets - world's first smart helmet pov race footage (full race)
-
6:05
german wwii helmets part 1
-
10:01
immutep limited (asx:imm, nasdaq:immp) encouraging results for immutep's cancer therapies
-
47:53
immutep (asx:imm, nasdaq:immp) tacti-003 results, june 2024
-
31:08
immutep (asx:imm) 2023 agm - ceo presentation
-
17:30
18 minutes with immutep ceo marc voigt
-
6:03
immutep (asx:imm, nasdaq:immp) reports positive discussions with the fda and strong survival data
-
27:17
immutep limited (asx:imm, nasdaq:immp) - fireside chat with immutep limited
-
4:19
immutep (asx:imm) clinical trial update
-
4:44
immutep (asx:imm, nasdaq:immp) - innovative cancer therapies
-
5:42
immutep (asx:imm, nasdaq:immp) receives fast track designation from fda - october 12, 2022
-
5:58
ausbiz interview with ceo marc voigt, march 17, 2021, immutep limited (asx: imm; nasdaq: immp)
-
4:40
immutep (asx:imm) announces encouraging trial data for lung cancer therapy
-
52:08
immutep (asx:imm, nasdaq:immp) global webcast presentation at sitc 2022
-
3:33
immutep (asx:imm) reports positive trial data
Clip.africa.com - Privacy-policy